FHA
DBTX

Flagship Harbor Advisors’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Flagship Harbor Advisors’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,113
Closed -$38.9K – 658
2023
Q2 		$38.9K Hold
10,113
– – ﹤0.01% 610
2023
Q1 		$30.5K Hold
10,113
– – ﹤0.01% 610
2022
Q4 		$20.7K Hold
10,113
– – ﹤0.01% 602
2022
Q3 		$35K Hold
10,113
– – ﹤0.01% 578
2022
Q2 		$43K Hold
10,113
– – ﹤0.01% 584
2022
Q1 		$31K Hold
10,113
– – ﹤0.01% 613
2021
Q4 		$47K Buy
+10,113
New +$69.6K ﹤0.01% 638

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM

Flagship Harbor Advisors's DBTX Position: Q3 2023 in Review

Flagship Harbor Advisors sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 10,113 shares — an estimated $38.9K sold.

Flagship Harbor Advisors first reported a position in DBTX in Q4 2021 and held it in 7 quarters. The position peaked at $47K in Q4 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Flagship Harbor Advisors reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Flagship Harbor Advisors sold 10,113 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $38.9K.
  • Flagship Harbor Advisors first reported a position in Decibel Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Flagship Harbor Advisors's Decibel Therapeutics, Inc. Common Stock position peaked at $47K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Flagship Harbor Advisors's 13F filing for Q3 2023, filed 17 Oct 2023.